A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease

Mahal, B. A., Margolis, M., Hubbell, E., Chen, C., Venstrom, J. M., Abran, J., … Klein, E. A. (2024). A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease. JCO Precision Oncology, (8). https://doi.org/10.1200/po.24.00269